- Patent Title: Methods of treating chronic disorders with complement inhibitors
-
Application No.: US17235281Application Date: 2021-04-20
-
Publication No.: US11712460B2Publication Date: 2023-08-01
- Inventor: Cedric Francois , Pascal Deschatelets
- Applicant: Apellis Pharmaceuticals, Inc.
- Applicant Address: US MA Waltham
- Assignee: Apellis Pharmaceuticals, Inc.
- Current Assignee: Apellis Pharmaceuticals, Inc.
- Current Assignee Address: US MA Waltham
- Agency: Choate, Hall & Stewart LLP
- Agent Melissa M. Adams; Dustin K. Goncharoff
- The original application number of the division: US16714252 2019.12.13
- Main IPC: A61K31/7088
- IPC: A61K31/7088 ; A61K31/7105 ; A61K38/48 ; A61K38/12 ; A61K38/10 ; A61B5/145 ; G01N33/68 ; A61K39/395 ; A61B5/00

Abstract:
In some aspects, the invention provides methods of treating a subject in need of treatment for a chronic complement-mediated disorder. In some aspects, the invention provides methods of treating a subject in need of treatment for a Th17-associated disorder. In some aspects, the invention provides methods of treating a subject in need of treatment for a chronic respiratory system disorder. In some aspects, the invention provides methods of administering a complement inhibitor to a subject. In some embodiments, a method of treating a subject comprises administering multiple doses of a complement inhibitor to the subject according to a dosing schedule that leverages the prolonged effect of complement inhibition in chronic respiratory disorders. In some embodiments, a subject has chronic obstructive pulmonary disease. In some embodiments, a subject has asthma.
Information query